At its J.P. Morgan Healthcare Conference 2026 presentation, Qiagen NV alluded to positive full-year results for 2025 and ...
Companies across the globe are diligently working toward developing novel Dry Age Macular Degeneration treatment therapies ...
Bruker (NASDAQ:BRKR) executives used a conference presentation and Q&A session to outline what they described as an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback